Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Young women with high male hormone levels or PCOS often feel more psychological distress and have a lower quality of life.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Older patients with Cushing's syndrome often have different symptoms and treatment outcomes compared to younger patients.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

The survey helps identify menstrual irregularities and excess male hormones, aiming to detect conditions like Polycystic Ovary Syndrome.

People with alopecia areata often have lower vitamin D levels than healthy people.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Recognizing and managing hirsutism, alopecia, and acne is crucial for improving wellbeing in women with PCOS.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Finasteride effectively treats hair loss in transgender men with few side effects.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testosterone improves mood and thinking skills; finasteride has no effect.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

Turkish women with hirsutism experience lower quality of life, especially those with PCOS, regardless of hair growth severity.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.